While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. Keeping that in mind, here are three profitable companies to steer clear of and a few better alternatives.
Conagra (CAG)
Trailing 12-Month GAAP Operating Margin: 3.1%
Founded in 1919 as Nebraska Consolidated Mills in Omaha, Nebraska, Conagra Brands today (NYSE: CAG) boasts a diverse portfolio of packaged foods brands that includes everything from whipped cream to jarred pickles to frozen meals.
Why Are We Out on CAG?
- Falling unit sales over the past two years imply it may need to invest in product improvements to get back on track
- Sales were less profitable over the last three years as its earnings per share fell by 13.8% annually, worse than its revenue declines
- Capital intensity has ramped up over the last year as its free cash flow margin decreased by 4.8 percentage points
At $14.04 per share, Conagra trades at 8.4x forward P/E. Read our free research report to see why you should think twice about including CAG in your portfolio.
Laureate Education (LAUR)
Trailing 12-Month GAAP Operating Margin: 24%
Founded in 1998 by Douglas L. Becker and based in Miami, Laureate Education (NASDAQ: LAUR) is a global network of higher education institutions.
Why Do We Pass on LAUR?
- Number of enrolled students has disappointed over the past two years, indicating weak demand for its offerings
- Performance over the past five years shows its incremental sales were less profitable, as its 4.2% annual earnings per share growth trailed its revenue gains
- Free cash flow margin is expected to remain in place over the coming year
Laureate Education is trading at $37.05 per share, or 18x forward P/E. If you’re considering LAUR for your portfolio, see our FREE research report to learn more.
Pediatrix Medical Group (MD)
Trailing 12-Month GAAP Operating Margin: 11.3%
With a network of approximately 2,620 affiliated physicians caring for some of the most vulnerable patients, Pediatrix Medical Group (NYSE: MD) provides specialized physician services focused on neonatal, maternal-fetal, pediatric cardiology and other pediatric subspecialty care across 37 states.
Why Are We Wary of MD?
- Sales tumbled by 1.7% annually over the last two years, showing market trends are working against it during this cycle
- Demand will likely be weak over the next 12 months as Wall Street expects flat revenue
- Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results
Pediatrix Medical Group’s stock price of $24.65 implies a valuation ratio of 10.6x forward P/E. Check out our free in-depth research report to learn more about why MD doesn’t pass our bar.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
